Thomson Reuters/Uni...
Health Care: Drugs
Teva Pharmaceutical Industries Ltd (TEVA: NYSE)
$40.23 0.27 | 0.68%
05/17/13 - 04:03 PM ET
3.45M / 4.09M
Vol / Avg. Vol:40.12 / 39.96
Open / Prev. Close:40.00 - 40.45
Today's Range:36.63 - 42.83
52 Wk Range:7.74%
Performance YTD:TheStreet Rating:
Portfolios with TEVA
- Portfolio NameUser Type
- UserDonnie Portfolio 2 High Grade
- UserMain
- UserLong Term Stock Picks
- UserTRIG
- Userfun and games
- Userabangser Portfolio 1
- ContributorHighest-Yielding Drug Stocks
- Contributor8 Pharma Stocks to Watch
- Userdividend
- UserIncome stocks
Latest TEVA Headlines from TheStreet
- 4 Stocks Improving Performance Of The Health Care Sector 05.16.13 | 01:05 pm
- 5 Stocks Going Ex-Dividend Tomorrow: LAND, RNDY, TROX, R, TEVA 05.15.13 | 10:05 am
- Teva Stock To Go Ex-dividend Tomorrow (TEVA) 05.15.13 | 09:05 am
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Health Care Winner 05.14.13 | 05:05 pm
- Teva Pharmaceutical Industries Ltd Stock Hold Recommendation Reiterated (TEVA) 05.10.13 | 10:05 am
- 'Mad Money' Lightning Round: Buy, Buy, Buy Biogen 05.10.13 | 06:05 am
- Cramer's 'Mad Money' Recap: Looking for Real Leaders 05.09.13 | 08:05 pm
- 5 Stocks Advancing The Drugs Industry 05.07.13 | 01:05 pm
- Teva Pharmaceutical Industries Ltd Stock Hold Recommendation Reiterated (TEVA) 04.29.13 | 10:04 am
- Teva Pharmaceutical Industries Ltd (TEVA): Today's Featured Drugs Winner 04.24.13 | 05:04 pm
Press Releases for TEVA
- Alexza Announces Conference Call To Discuss Agreement With Teva To Market ADASUVE® In The U.S. - PR Newswire 05.08.13 | 08:05 am
- Teva And Alexza Announce Teva's License To Market ADASUVE® In The U.S. - PR Newswire 05.08.13 | 08:05 am
- OncoGenex Announces Plans For The Initiation Of The Rainier⿢ Clinical Trial Evaluating OGX-427 In Combination With ABRAXANE® Plus Gemcitabine In Patients With Metastatic Pancreatic Cancer - PR Newswire 05.01.13 | 06:05 am
- OncoGenex Announces That The Borealis-2â¿¢ Clinical Trial Of OGX-427 In Previously Treated Metastatic Bladder Cancer Is Now Open For Enrollment - PR Newswire 04.30.13 | 08:04 am
- More Than Half Of Nasal Allergy Sufferers Experience Sleep Issues, Yet Many Fail To Adequately Prepare In Advance Of Peak Allergy Seasons - PR Newswire 04.23.13 | 08:04 am
- Apolo Anton Ohno And Teva Respiratory Announce Finalists In National EIB All Starsâ¿¢ Contest - PR Newswire 04.16.13 | 08:04 am
- OncoGenex Announces Plans For The Initiation Of The Spruceâ¿¢ Clinical Trial Evaluating OGX-427 In Combination With Chemotherapy In Advanced Non-Squamous Non-Small Cell Lung Cancer - PR Newswire 04.11.13 | 08:04 am
- Early Versus Delayed Treatment With Laquinimod Demonstrated Significant Reduction In Risk Of Disability Progression – Results Of Three-Year ALLEGRO Study In Relapsing-Remitting Multiple Sclerosis - Business Wire 03.21.13 | 08:03 am
- New Data Show Azilect® (rasagiline Tablets) Provided Clinical Benefit In Patients With Early Parkinson’s When Added To Sub-Optimally Controlled Patients On Dopamine Agonist Therapy - Business Wire 03.20.13 | 07:03 am
- Teva To Present New Research On CNS Product Portfolio And Pipeline At 2013 American Academy Of Neurology Annual Meeting - Business Wire 03.14.13 | 09:03 am
Partner Headlines for TEVA
- Analysts: SanDisk Will Beat Estimates and 4 New Opinions Investors Must Take Note Of - Wall St. Cheat Sheet 04.02.13 | 11:04 am
- 10 Sharp Healthcare Dogs Diagnose 7.4% To 62.1% Gains In March - Seeking Alpha 04.01.13 | 09:04 am
- FDA Approves NDA for Teva's Quartette Tablets to Prevent Pregnancy - Benzinga 03.29.13 | 11:03 am
- Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy - Seeking Alpha 03.28.13 | 09:03 am
- Biogen MS Drug Approved; No 'Black Box' Label - Investor's Business Daily 03.27.13 | 06:03 pm
- Drug Companies Have Rebounded From The Patent Cliff With Acquisitions Now On The Mind - Seeking Alpha 03.25.13 | 09:03 am
- Valeant Earnings, Sales Top Estimates; Street Shrugs - Investor's Business Daily 02.28.13 | 05:02 pm
- 3 Industries Set To Profit From An Aging Population - Seeking Alpha 01.31.13 | 09:01 am
- Amgen Q4 Sales, 2013 Guidance Modestly Beat Estimates - Investor's Business Daily 01.23.13 | 06:01 pm
- Teva Pharmaceuticals - Food For Thought - Seeking Alpha 01.15.13 | 08:01 am
